BIO.News Newsletter

It’s been a good week for biotech trials. Nkarta Therapeutics, led by BIO’s Chair, announced positive data in two trials of its natural killer cell therapies targeting advanced blood cancer, and gene edited mosquitoes “behaved as planned” in the first trial in the Florida Keys. (632 words, 3 minutes, 9 seconds)

Congress is back to work, and there are new calls for a SAF tax credit—here’s why. Plus, it’s World Immunization Week, so we discuss a few recent vaccine successes and why routine vaccinations are important. (556 words, 2 minutes, 46 seconds)

Today is Earth Day—so we’re looking at the links between air quality and human health, and how biotech can deliver solutions for a cleaner, healthier planet and population. Also, everyone’s talking about PBMs—but what exactly are they? (594 words, 2 minutes, 58 seconds)

A new report explains the risk of not investing in the U.S. bioeconomy. We also have an exclusive look at a public-private partnership fostering clinical trials in Africa and improving health care infrastructure and lives as a result. (635 words, 3 minutes, 10 seconds)

A new study provides more evidence that hospitals—not manufacturers—often determine what patients and insurers pay for lifesaving cancer drugs. Meanwhile, House Ways & Means Republicans reintroduced a tax package that would provide incentives for drug R&D, especially for small biotechs. (709 words, 3 minutes, 32 seconds)

ICYMI: CMS announced they’ll only cover a breakthrough Alzheimer’s drug for patients in clinical trials. In a new exclusive, we talk to BIO experts about the impact. Also, today’s new episode of the I am BIO Podcast talks to two people who helped a flight powered by 100% SAF take off. (753 words, 3 minutes, 45 seconds)

Whatever you celebrate—Easter, Passover, Ramadan, spring—we hope you enjoyed the weekend and quality time with family and friends. We’re back in action with news on COVID-19 vaccines and biofuels that you might have missed. (537 words, 2 minutes, 41 seconds)

We’re interrupting your spring break with Biden’s big announcement on bioethanol—plus, details on BIO’s new Early-Stage Advisory Council and more news links. (675 words, 3 minutes, 22 seconds)

We hear a lot of folks are on spring break this week for Easter and Passover, so we want to share some spring break reading and podcasts in case you have some extra time this week. And if you don’t, we plan to pop in with news from time to time, so stay tuned. We’ll return to our regular publishing schedule on Monday, April 18. (362 words, 2 minutes)

CMS released its unprecedented final coverage determination for a breakthrough Alzheimer’s drug—we have the details and why it’s an enormous setback for Alzheimer’s patients and a dangerous infringement on FDA’s autonomy. Plus, we mark the 50th birthday of APHIS. (683 words, 3 minutes, 24 seconds)